A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 378
Comprehensive Pages
- 35
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic and Economic Breakouts
2025 IOL Market Report: Global Analysis for 2024 to 2030, March, 2025
The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Latest Industry News & Trends
6/13/2025
BreakingCataractDealsPharma
Harrow Acquires US Rights to Formosa’s Clobetasol, Now Branded Byqlovi
Harrow announced June 9 that it had acquired the US commercial rights to Formosa Pharmaceuticals’ clobetasol propionate 0.05% eye drops for postsurgical inflammation and pain. According to a filing...
6/13/2025
BreakingCornealDealsEuropeIOLPharma
Spain’s Faes Farma Acquires Italy’s SIFI in Deal Worth $310.4 Million
Faes Farma, of Bilbao, Spain, announced June 11 that it had signed an agreement to acquire 100 percent of Italian ophthalmic company SIFI. The deal values SIFI at €270 million (US $310.4 million, c...
6/13/2025
BreakingGlaucomaPharma
Qlaris Bio Will Advance Fixed-Dose Combo Therapy for Glaucoma with QLS‑111 and Latanoprost
Qlaris Bio announced June 11 that it is developing a preservative-free, fixed-dose combination therapy with its lead asset, QLS-111, and latanoprost, a common prostaglandin analog prescribed for gl...
6/13/2025
BreakingChinaDiagnosticFundusRegulation
Chinese Regulators Approve Clarus 700 Ultra-Widefield Fundus Camera from Zeiss
Germany’s Carl Zeiss Meditec announced June 6 that China’s National Medical Products Administration (NMPA) had approved the Clarus 700 high-definition, ultra-widefield fundus imaging system. The co...
6/13/2025
BreakingGene TherapyIndustryRetina
Beacon Therapeutics Appoints Daniel Chung, DO, as Chief Medical Officer
Beacon Therapeutics announced June 9 that it had appointed Daniel Chung, DO, as chief medical officer. Chung most recently served as chief medical officer of the ophthalmic gene therapy company Spa...
6/13/2025
BreakingGene TherapyIndustryRegulationRetina
ViGeneron Rebrands as VeonGen, Gains Rare Pediatric Nod for Stargardt Candidate
Germany’s ViGeneron announced June 5 its rebranding to VeonGen Therapeutics. VeonGen has advanced two gene therapy programs into clinical development—VG801 for Stargardt disease and other ABCA4-rel...
6/6/2025
BreakingPharmaRegulation
FDA Begins Listening Tour with Pharma CEOs to Improve Regulatory Process
The US FDA is holding a listening tour, led by FDA Commissioner Marty A. Makary, MD, MPH,to meet directly with pharmaceutical and biotech CEOs, according to an announcement on May 28. The goal is t...
6/6/2025
BreakingCataractDealsEuropeRefractiveSurgical
EssilorLuxottica to Acquire European Ophthalmology Clinic Chain Optegra
Eyewear conglomerate EssilorLuxottica announced May 30 that it would acquire the Optegra chain of ophthalmology clinics from the private equity firm MidEuropa. Financial details were not disclosed....
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.